Articles

• Open Access

  High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS

  Simon Thebault, Daniel R. Tessier, Hyunwoo Lee, Marjorie Bowman, Amit Bar-Or, Douglas L. Arnold, Harold L. Atkins, Vincent Tabard-Cossa, Mark S. Freedman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD

  Lawrence J. Cook, John W. Rose, Jessica S. Alvey, Anna Marie Jolley, Renee Kuhn, Brie Marron, Melissa Pederson, Rene Enriquez, Jeff Yearley, Stephen McKechnie, May H. Han, Anna J. Tomczak, Michael Levy, Maureen A. Mealy, Jessica Coleman, Jeffrey L. Bennett, Ruth Johnson, Myka Barnes-Garcia, Anthony L. Traboulsee, Robert L. Carruthers, Lisa Eunyoung Lee, Julia J. Schubert, Katrina McMullen, Ilya Kister, Zoe Rimler, Allyson Reid, Nancy L. Sicotte, Sarah M. Planchon, Jeffrey A. Cohen, Diane Ivancic, Jennifer L. Sedlak, Ilana Katz Sand, Pavle Repovic, Lilyana Amezcua, Ana Pruitt, Erika Amundson, Tanuja Chitnis, Devin S. Mullin, Eric C. Klawiter, Andrew W. Russo, Claire S. Riley, Kaho B. Onomichi, Libby Levine, Katherine E. Nelson, Nancy M. Nealon, Casey Engel, Mason Kruse-Hoyer, Melanie Marcille, Leticia Tornes, Anne Rumpf, Angela Greer, Megan Kenneally Behne, Renee R. Rodriguez, Daniel W. Behne, Derek W. Blackway, Brian Coords, Terrence F. Blaschke, Judy Sheard, Terry J. Smith, Jacinta M. Behne, Michael R. Yeaman, on behalf of The Guthy-Jackson Charitable Foundation International Clinical Consortium (GJCF–ICC)

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Does CSF pleocytosis have a predictive value for disease course in MS?

  Itay Lotan, Felix Benninger, Rom Mendel, Mark A. Hellmann, Israel Steiner

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes

  Ari Breiner, Carolina Barnett Tapia, Leif Erik Lovblom, Bruce A. Perkins, Hans D. Katzberg, Vera Bril

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Gray matter microglial activation in relapsing vs progressive MSA [F-18]PBR06-PET study

  Tarun Singhal, Kelsey O'Connor, Shipra Dubey, Hong Pan, Renxin Chu, Shelley Hurwitz, Steven Cicero, Shahamat Tauhid, David Silbersweig, Emily Stern, Marie Kijewski, Marcelo DiCarli, Howard L. Weiner, Rohit Bakshi

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Systemic inflammatory response syndrome and long-term outcome after intracerebral hemorrhage

  Manuel Hagen, Jochen A. Sembill, Maximilian I. Sprügel, Stefan T. Gerner, Dominik Madžar, Hannes Lücking, Philip Hölter, Stefan Schwab, Hagen B. Huttner, Joji B. Kuramatsu

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDPPATH extension study

  Ivo N. van Schaik, Orell Mielke, Vera Bril, Nan van Geloven, Hans-Peter Hartung, Richard A. Lewis, Gen Sobue, John-Philip Lawo, Michaela Praus, Billie L. Durn, David R. Cornblath, Ingemar S. J. Merkies, on behalf of the PATH study group

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS

  Angelo Ghezzi, Giancarlo Comi, Luigi Maria Grimaldi, Lucia Moiola, Carlo Pozzilli, Simone Fantaccini, Paolo Gallo

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Novel clinical features of glycine receptor antibody syndromeA series of 17 cases

  Amanda L. Piquet, Murtaza Khan, Judith E.A. Warner, Matthew P. Wicklund, Jeffrey L. Bennett, Maureen A. Leehey, Lauren Seeberger, Teri L. Schreiner, M. Mateo Paz Soldan, Stacey L. Clardy

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Lesion activity and chronic demyelination are the major determinants of brain atrophy in MS

  Chenyu Wang, Michael H. Barnett, Con Yiannikas, Joshua Barton, John Parratt, Yuyi You, Stuart L. Graham, Alexander Klistorner

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Hepatitis E virus infections in patients with MS on oral disease-modifying treatment

  Martin Diebold, Bettina Fischer-Barnicol, Charidimos Tsagkas, Jens Kuhle, Ludwig Kappos, Tobias Derfuss, Bernhard F. Décard

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS

  Sinah Engel, Michaela Friedrich, Muthuraman Muthuraman, Falk Steffen, Alicia Poplawski, Sergiu Groppa, Stefan Bittner, Frauke Zipp, Felix Luessi

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS

  Maria Cellerino, Christian Cordano, Giacomo Boffa, Giulia Bommarito, Maria Petracca, Elvira Sbragia, Giovanni Novi, Caterina Lapucci, Elisabetta Capello, Antonio Uccelli, Matilde Inglese

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)

  William Camu, Philippe Lehert, Charles Pierrot-Deseilligny, Patrick Hautecoeur, Anne Besserve, Anne-Sophie Jean Deleglise, Marianne Payet, Eric Thouvenot, Jean Claude Souberbielle

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Anti–pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy

  Helena Stengel, Atay Vural, Anna-Michelle Brunder, Annika Heinius, Luise Appeltshauser, Bianca Fiebig, Florian Giese, Christian Dresel, Aikaterini Papagianni, Frank Birklein, Joachim Weis, Tessa Huchtemann, Christian Schmidt, Peter Körtvelyessy, Carmen Villmann, Edgar Meinl, Claudia Sommer, Frank Leypoldt, Kathrin Doppler

  • Abstract
  • Full Text
  • Full Text (PDF)